Skip to main content

Abstract

Endopeel® Gluteoplasty: Three-Dimensional Isovolumetric Myotension as a Minimally Invasive Myoplasty–Myopexy Technique for Immediate Buttock Projection

Introduction

Gluteal aesthetics have become a major focus in body contouring surgery. Standard augmentation methods include prosthetic implants and autologous fat grafting (“Brazilian Butt Lift”). Although effective in increasing volume, these procedures carry recognized risks including infection, seroma, fat necrosis, capsular contracture, and pulmonary fat embolism.

Non-surgical approaches—such as hyaluronic acid fillers, poly-L-lactic acid stimulators, platelet-rich plasma (PRP), and exosome-based treatments—aim to improve contour via volumization or biostimulation. However, these techniques do not fundamentally address muscular architecture and may present vascular or inflammatory risks.

Endopeel® gluteoplasty introduces a different therapeutic concept: functional myoplasty and myopexy achieved through controlled three-dimensional isovolumetric myotension, producing immediate projection without adding volume.

Materials and Methods

Study Design

Prospective observational clinical series.

Patient Selection

Inclusion criteria:

  • Mild-to-moderate gluteal ptosis

  • Insufficient projection without major skin redundancy

  • No prior gluteal implants or recent volumetric fillers

Exclusion criteria:

  • Active infection

  • Severe tissue laxity requiring surgical excision

Procedure

Precise anatomical mapping of the gluteus maximus was performed. Targeted intramuscular microinjections were administered to induce controlled isovolumetric contraction. The mechanism produces:

  • Myoplasty (functional muscular reshaping)

  • Myopexy (elevation via tension vectors)

  • 3D projection enhancement

No fillers, implants, fat grafts, or volumizing agents were used.

Outcome Measures

  • Immediate photographic assessment

  • Projection analysis

  • Complication monitoring

  • Patient-reported satisfaction

Results

  • Immediate gluteal elevation observed intra-procedurally

  • Enhanced upper pole projection

  • Improved contour definition

Safety Profile

  • Only transient ecchymoses reported

  • No downtime

  • No necrosis

  • No infection

  • No embolic events

  • No tissue atrophy

  • No foreign-body reaction

All patients resumed daily activity immediately post-procedure.

Discussion

Mechanistic Distinction

Unlike volumetric augmentation, Endopeel® gluteoplasty does not rely on tissue addition but on functional muscular reconfiguration.

Comparative Critical Analysis

Autologous Fat Grafting (BBL):

  • Requires anesthesia and operating room

  • Risk of fat embolism (potentially fatal)

  • Variable graft survival

  • Postoperative downtime

Synthetic Fillers (HA, PLLA, etc.):

  • Risk of vascular occlusion

  • Foreign-body reactions

  • Delayed inflammatory nodules

  • Limited structural lift

PRP and Exosomes:

  • Primarily regenerative or biostimulatory

  • Lack structural lifting capacity

  • Variable scientific validation

  • No immediate mechanical projection

Gluteal Implants:

  • Capsular contracture risk

  • Implant displacement

  • Infection

  • Surgical morbidity

Advantages of Endopeel® Gluteoplasty

  • Immediate effect

  • Isovolumetric mechanism

  • No foreign body

  • No embolic risk

  • No surgical incision

  • Zero downtime

  • Minimal complication profile

The procedure addresses muscular vector mechanics rather than superficial volume, providing a distinct therapeutic niche between non-surgical volumization and operative augmentation.

Conclusion

Endopeel® gluteoplasty represents a novel paradigm in buttock enhancement based on three-dimensional isovolumetric myotension, myoplasty, and myopexy. It achieves immediate projection and elevation without volumetric augmentation or surgery. The safety profile appears favorable, with transient ecchymosis as the only observed adverse event. Further controlled studies are warranted to evaluate long-term durability and reproducibility.

Keywords

Endopeel®; Gluteoplasty; Myoplasty; Myopexy; Isovolumetric Myotension; Non-surgical Buttock Enhancement; Functional Muscle Modulation; Minimally Invasive Body Contouring

Conflict of Interest

The author is the developer of the Endopeel® technique.

Ethics Statement

All procedures were performed in accordance with ethical medical standards and informed consent was obtained from all patients. The study followed the principles of the Declaration of Helsinki.

Level of Evidence

Level IV – Therapeutic Study (Case Series).